Cowen and Company’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-272
Closed -$408 668
2023
Q1
$408 Buy
272
+136
+100% +$18.5K ﹤0.01% 562
2022
Q4
$2.72K Buy
+136
New +$46K ﹤0.01% 540
2021
Q4
Sell
-5,818
Closed -$102K 809
2021
Q3
$102K Buy
5,818
+4,366
+301% +$5.29M ﹤0.01% 310
2021
Q2
$185K Buy
+1,452
New +$1.96M 0.01% 288

Other funds holding CANO

Cowen and Company's CANO Position: Q2 2023 in Review

Cowen and Company sold out of Cano Health, Inc. (CANO) in Q2 2023, closing a stake of 400 shares — an estimated $36.4K sold.

Cowen and Company first reported a position in CANO in Q3 2020 and held it in 3 quarters. The position peaked at $3.28M in Q3 2021. 154 funds tracked by Wall St. Rank hold CANO as of Q2 2023.

  • Cowen and Company reported no remaining Cano Health, Inc. position as of Q2 2023 after selling out during the quarter.
  • Cowen and Company sold 400 Cano Health, Inc. shares in Q2 2023, an estimated $36.4K.
  • Cowen and Company first reported a position in Cano Health, Inc. in Q3 2020 and held it in 3 quarters.
  • Cowen and Company's Cano Health, Inc. position peaked at $3.28M in Q3 2021.
  • 154 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2023.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.